Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward
Portfolio Pulse from
Cibus, Inc. (Nasdaq: CBUS) welcomes the EU's progress on legislation for New Genomic Techniques (NGTs), which aims to adapt EU law to scientific advancements, allowing NGT products to enhance sustainable agriculture. The legislation proposes a 'conventional-like' category for NGT-1 products, aligning EU regulations with global standards.
March 17, 2025 | 11:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cibus, Inc. supports the EU's legislative progress on New Genomic Techniques, which could enhance the company's market opportunities in Europe by aligning regulations with global standards.
The EU's move to align its regulations on New Genomic Techniques with global standards could open up new market opportunities for Cibus, Inc., which develops plant traits using these techniques. This alignment may facilitate easier market entry and expansion for Cibus in the European market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90